Hempsana Inc. Announces Appointment of a Proposal Trustee
TORONTO, March 13, 2024 (GLOBE NEWSWIRE) — Hempsana Holdings Ltd. (HMPS.CN) announces that on March 11, 2024, its wholly-owned operating […]
FLUENT Prioritizes Reinvestment into Florida-Based Cultivation Facilities with Multiple Renovations and Expansions
TAMPA, Fla., March 13, 2024 (GLOBE NEWSWIRE) — Cansortium Inc. (CSE: TIUM.U) (OTCQB: CNTMF) (“Cansortium” or the “Company”), a vertically-integrated, […]
Draganfly to Integrate Drones with Knightscope Autonomous Security Robots & Systems
Knightscope Autonomous Security Robots (ASRs) & Emergency Communications Products to be Integrated with Draganfly Drones for Innovation in Public Safety. […]
Netcoins USA announces partnership with Zero Hash to deliver crypto trading in 48 states
VANCOUVER, British Columbia, March 13, 2024 (GLOBE NEWSWIRE) — BIGG Digital Assets Inc. (“BIGG” or the “Company”) (CSE: BIGG; OTCQX: […]
Clearmind Medicine Obtains Clearance for its Psychedelic- Based Alcoholism Clinical Trial
Vancouver, Canada, March 13, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”), […]
Clearmind Medicine Received Approval for a Voluntary Delisting of its Common Shares From the Canadian Securities Exchange
Vancouver, Canada, March 13, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”), […]
AYR Wellness Reports Fourth Quarter and Full Year 2023 Results
FY 2023 Revenue up 10% to $463.6 Million, Excluding Discontinued Operations FY 2023 GAAP Loss from Operations Improved to $37.2 […]
Spirit Blockchain Capital and Vesta Equity Announce Strategic Mutual Investment
Please click here to view image VANCOUVER, British Columbia, March 12, 2024 (GLOBE NEWSWIRE) — Spirit Blockchain Capital Inc. (the […]
Madison Metals Announces Non-Brokered Private Placement
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, March 12, 2024 (GLOBE NEWSWIRE) — […]
Psyence Group’s NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) — Psyence Group Inc (“Psyence Group“) (CSE: PSYG), a clinical-stage life science biotechnology […]
